Plozalizumab (Anti-CCR2 / CD192)
Plozalizumab (Anti-CCR2 / CD192) is a specific humanized monoclonal antibody targeting CCR2. Plozalizumab can be used for malignant melanoma research. MW:145.5 KD.
| Trivial name | MLN-1202 |
| Catalog Number | A2569 |
| CAS# | 1610761-46-0 |
| Size | 1mg |
| Supplier Page | http://www.selleckchem.com/products/plozalizumab-anti-ccr2-cd192.html |